Zacks.com on MSN1d
Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock
Medtronic's Medical Surgical segment faces challenges in the third quarter due to shifts in U.S. distributor buying patterns.
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s ...
Nasdaq5d
After A Mixed Q3 Where Does Medtronic Stock Go From Here?
Medtronic (NYSE: MDT) recently announced its Q3 fiscal 2025 results (fiscal ends in April), reporting revenue of $8.29 billion, slightly below the $8.33 billion consensus estimate. Adjusted ...
Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Medtronic’s (NYSE: MDT) growth efforts and investments in medical technology innovation are starting to pay off. The ...
Medtronic price target raised to $85 from $83 at Goldman Sachs
Goldman Sachs analyst David Roman raised the firm’s price target on Medtronic (MDT) to $85 from $83 and keeps a Sell rating on the shares. The ...
Business Insider6d
Medtronic price target raised to $93 from $89 at Truist
Truist raised the firm’s price target on Medtronic (MDT) to $93 from $89 and keeps a Hold rating on the shares after its Q3 earnings beat. Despite the organic revenue miss, Medtronic saw high ...
ETF Daily News5d
FY2025 EPS Estimates for Medtronic Raised by William Blair
William Blair also issued estimates for Medtronic’s Q3 2026 earnings at $1.44 EPS and FY2026 earnings at $5.81 EPS. Get Medtronic alerts: MDT has been the topic of several other reports.
Benzinga.com5d
Medtronic's Expansion Gains Momentum—Time for a Market Shift?
Medtronic had a decent quarter ... Guidance is another reason a stock market reversal is still possible. The Q3 results were tepid, but guidance was reaffirmed in a range with consensus targets ...